National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 8) (PB 102 of 2015) (Cth)

Case

PB 102 of 2015

National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 8)

National Health Act 1953

I, PAUL CREECH, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated    23 October 2015

PAUL CREECH
First Assistant Secretary (Acting)
Pharmaceutical Benefits Division
Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2015 (No. 8).

(2)        This Instrument may also be cited as PB 102 of 2015.

2          Commencement

This Instrument commences on 1 November 2015.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1]Schedule 1, entry for Aciclovir in the form Tablet 200 mg [Pricing Quantity/Pack Quantity: 25]

(a)   omit from the column headed “Determined Price”:             10.38     substitute:             8.30

(b)   omit from the column headed “Claimed Price”:                  11.21     substitute:             8.96

[2]Schedule 1, entry for Aciclovir in the form Tablet 200 mg [Pricing Quantity/Pack Quantity: 90]

omit from the column headed “Claimed Price”:          38.76     substitute:             30.99

[3]Schedule 1, entry for Aciclovir in the form Tablet 800 mg

(a)   omit from the column headed “Determined Price”:             45.19     substitute:             36.15

(b)   omit from the column headed “Claimed Price”:                  45.87     substitute:             36.70

[4]Schedule 1, entry for Alendronic acid with colecalciferol

(a)   omit from the column headed “Determined Price”:             31.85     substitute:             26.91

(b)   omit from the column headed “Claimed Price”:                  34.17     substitute:             28.87

[5]Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg

(a)   omit from the column headed “Determined Price”:             14.01     substitute:             11.96

(b)   omit from the column headed “Claimed Price”:                  16.81     substitute:             14.35

[6]Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg

(a)   omit from the column headed “Determined Price”:             17.51     substitute:             14.94

(b)   omit from the column headed “Claimed Price”:                  20.31     substitute:             17.33

[7]Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 10 mg

(a)   omit from the column headed “Determined Price”:             21.89     substitute:             18.68

(b)   omit from the column headed “Claimed Price”:                  24.69     substitute:             21.07

[8]Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg

(a)   omit from the column headed “Determined Price”:             1.11        substitute:             0.88

(b)   omit from the column headed “Claimed Price”:                  2.98        substitute:             2.36

[9]Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg

(a)   omit from the column headed “Determined Price”:             3.30        substitute:             2.62

(b)   omit from the column headed “Claimed Price”:                  5.16        substitute:             4.10

  1. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg

    (a)   omit from the column headed “Determined Price”:             9.88        substitute:             7.85

    (b)   omit from the column headed “Claimed Price”:                  11.74     substitute:             9.33

  2. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg

    (a)   omit from the column headed “Determined Price”:             11.94     substitute:             9.49

    (b)   omit from the column headed “Claimed Price”:                  13.80     substitute:             10.97

  3. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg

    (a)   omit from the column headed “Determined Price”:             13.00     substitute:             8.96

    (b)   omit from the column headed “Claimed Price”:                  14.62     substitute:             10.08

  4. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg

    (a)   omit from the column headed “Determined Price”:             15.47     substitute:             10.66

    (b)   omit from the column headed “Claimed Price”:                  17.09     substitute:             11.78

  5. Schedule 1, entry for Candesartan with Hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg

    (a)   omit from the column headed “Determined Price”:             16.64     substitute:             11.47

    (b)   omit from the column headed “Claimed Price”:                  18.26     substitute:             12.59

  6. Schedule 1, entry for Cephalexin in the form Capsule 250 mg (anhydrous)

    (a)   omit from the column headed “Determined Price”:             0.91        substitute:             0.81

    (b)   omit from the column headed “Claimed Price”:                  4.41        substitute:             3.93

  7. Schedule 1, entry for Cephalexin in the form Capsule 500 mg (anhydrous)

    (a)   omit from the column headed “Determined Price”:             1.64        substitute:             1.46

    (b)   omit from the column headed “Claimed Price”:                  6.73        substitute:             5.99

  8. Schedule 1, entry for Cephalexin in the form Granules for oral suspension 125 mg per 5 mL, 100 mL

    (a)   omit from the column headed “Determined Price”:             1.09        substitute:             0.97

    (b)   omit from the column headed “Claimed Price”:                  4.95        substitute:             4.41

  9. Schedule 1, entry for Cephalexin in the form Granules for oral suspension 250 mg per 5 mL, 100 mL

    (a)   omit from the column headed “Determined Price”:             1.62        substitute:             1.45

    (b)   omit from the column headed “Claimed Price”:                  6.66        substitute:             5.96

  1. Schedule 1, entry for Ciprofloxacin in the form Tablet 250 mg (as hydrochloride)

    (a)   omit from the column headed “Determined Price”:             4.41        substitute:             3.60

    (b)   omit from the column headed “Claimed Price”:                  5.55        substitute:             4.53

  2. Schedule 1, entry for Ciprofloxacin in the form Tablet 500 mg (as hydrochloride)

    (a)   omit from the column headed “Determined Price”:             8.62        substitute:             7.03

    (b)   omit from the column headed “Claimed Price”:                  9.67        substitute:             7.96

  3. Schedule 1, entry for Citalopram in the form Tablet 20 mg (as hydrobromide)

    (a)   omit from the column headed “Determined Price”:             2.00        substitute:             1.60

    (b)   omit from the column headed “Claimed Price”:                  6.60        substitute:             5.28

  4. Schedule 1, entry for Clarithromycin

    (a)   omit from the column headed “Determined Price”:             2.80        substitute:             2.47

    (b)   omit from the column headed “Claimed Price”:                  5.63        substitute:             4.97

  5. Schedule 1, omit entry for Desferrioxamine

  6. Schedule 1, entry for Glimepiride in the form Tablet 1 mg

    (a)   omit from the column headed “Determined Price”:             1.15        substitute:             1.02

    (b)   omit from the column headed “Claimed Price”:                  3.50        substitute:             3.10

  7. Schedule 1, entry for Glimepiride in the form Tablet 2 mg

    (a)   omit from the column headed “Determined Price”:             2.20        substitute:             1.95

    (b)   omit from the column headed “Claimed Price”:                  4.49        substitute:             3.98

  8. Schedule 1, entry for Glimepiride in the form Tablet 3 mg

    (a)   omit from the column headed “Determined Price”:             2.80        substitute:             2.48

    (b)   omit from the column headed “Claimed Price”:                  5.10        substitute:             4.52

  9. Schedule 1, entry for Glimepiride in the form Tablet 4 mg

    (a)   omit from the column headed “Determined Price”:             3.44        substitute:             3.05

    (b)   omit from the column headed “Claimed Price”:                  5.74        substitute:             5.09

  10. Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 50 mg [Brand: Betaloc]

    (a)   omit from the column headed “Determined Price”:             2.20        substitute:             1.98

    (b)   omit from the column headed “Claimed Price”:                  5.25        substitute:             4.73

  1. Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 50 mg [Brand: Lopresor 50]

    (a)   omit from the column headed “Determined Price”:             2.20        substitute:             1.98

    (b)   omit from the column headed “Claimed Price”:                  3.83        substitute:             3.45

  2. Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 100 mg [Brand: Betaloc]

    (a)   omit from the column headed “Determined Price”:             2.81        substitute:             2.52

    (b)   omit from the column headed “Claimed Price”:                  5.85        substitute:             5.25

  3. Schedule 1, entry for Metoprolol in the form Tablet containing metoprolol tartrate 100 mg [Brand: Lopresor 100]

    (a)   omit from the column headed “Determined Price”:             2.81        substitute:             2.52

    (b)   omit from the column headed “Claimed Price”:                  4.43        substitute:             3.97

  4. Schedule 1, entry for Roxithromycin in the form Tablet 150 mg

    (a)   omit from the column headed “Determined Price”:             1.78        substitute:             1.56

    (b)   omit from the column headed “Claimed Price”:                  3.50        substitute:             3.07

  5. Schedule 1, entry for Roxithromycin in the form Tablet 300 mg

    (a)   omit from the column headed “Determined Price”:             1.78        substitute:             1.56

    (b)   omit from the column headed “Claimed Price”:                  3.50        substitute:             3.07

  6. Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Brands: Lipex 10; Zocor]

    (a)   omit from the column headed “Determined Price”:             1.77        substitute:             1.38

    (b)   omit from the column headed “Claimed Price”:                  4.46        substitute:             3.48

  7. Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Brands: Lipex 20; Zocor]

    (a)   omit from the column headed “Determined Price”:             2.56        substitute:             2.00

    (b)   omit from the column headed “Claimed Price”:                  5.25        substitute:             4.10

  8. Schedule 1, entry for Simvastatin in the form Tablet 40 mg [Brands: Lipex 40; Zocor]

    (a)   omit from the column headed “Determined Price”:             3.68        substitute:             2.87

    (b)   omit from the column headed “Claimed Price”:                  6.37        substitute:             4.97

  9. Schedule 1, entry for Simvastatin in the form Tablet 80 mg [Brands: Lipex 80; Zocor]

    (a)   omit from the column headed “Determined Price”:             5.28        substitute:             4.12

    (b)   omit from the column headed “Claimed Price”:                  7.97        substitute:             6.22

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0